89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Breast Cancer|HER2-positive Breast Cancer|Gastric Cancer|Metastatic Gastric Cancer|HER2-positive Gastric Cancer
Interventions: DIAGNOSTIC_TEST: 89Zr-DFO*-trastuzumab PET scan
Sponsor: Amsterdam UMC, location VUmc
Collaborators: AstraZeneca